Global Clinical Trials Matching Software Market Size, Share, and COVID-19 Impact Analysis, By Deployment Mode (Web & Cloud-Based and On-Premise), By End User (Pharmaceutical & Biotechnology Companies, CROs, and Medical Device Companies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Global Clinical Trials Matching Software Market Insights Forecasts to 2033  

• The Global Clinical Trials Matching Software Market Size was Estimated at USD 164.83 Million in 2023
• The Global Clinical Trials Matching Software Market Size is Expected to Grow at a CAGR of around 13.46% from 2023 to 2033
• The Worldwide Clinical Trials Matching Software Market Size is Expected to Reach USD 582.80 Million by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Clinical Trials Matching Software Market Size is Expected to cross USD 582.80 Million by 2033, Growing at a CAGR of 13.46% from 2023 to 2033. Improving patient recruitment, streamlining trial operations, allocating resources optimally, increasing trial success rates, and advancing medical research worldwide are opportunities for clinical trials matching software market.   

Market Overview  

The industry that develops and implements specialized software solutions to make it easier to connect patients, doctors, or research participants with appropriate clinical trials is known as the clinical trials matching software market. The clinical trials matching software market for these devices includes apps that use data analytics, artificial intelligence, and sophisticated algorithms to increase the success rate of clinical trials, streamline hiring procedures, and improve accessibility. The growing need to improve trial efficiency, the expanding complexity of clinical trials, and the growing use of AI and machine learning in patient recruitment are all factors driving the clinical trials matching software market. Research digitalization is creating opportunities for the growth of the clinical trials matching software market. The increasing incidence of chronic illnesses and the growing need for clinical trials are likely the main factors driving the clinical trials matching software market growth. The market for clinical trials matching software is expected to be driven by the growing number of clinical studies conducted worldwide.     

Report Coverage

This research report categorizes the clinical trials matching software market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the clinical trials matching software market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the clinical trials matching software market.  

Driving Factors

The need to improve trial efficiency, the growing complexity of clinical trials, the use of AI and machine learning in patient recruitment, and the growing need for advanced treatment solutions as a result of the rising incidence of chronic diseases are some of the major factors driving the growth of the clinical trials matching software market. The market for clinical trial matching software is being driven by the rise in drug trial activity. One factor driving the clinical trials matching software market is the growing number of businesses providing modern, personalized features.    

Restraining Factors

Data privacy issues, limited compatibility with current systems, high installation costs, stakeholder ignorance, legal obstacles, and reluctance to embrace new technology are some of the difficulties restricting the clinical trials matching software market.   

Market Segmentation  

The clinical trials matching software market share is classified into deployment mode and end user.        

• The web & cloud-based segment held the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.

Based on the deployment mode, the clinical trials matching software market is divided into web & cloud-based, and on-premise. Among these, the web & cloud-based segment held the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. The cloud computing concept, which requires no maintenance costs, is the reason for the web & cloud-based category. These systems facilitate seamless integration, cooperation, and real-time data exchange amongst many stakeholders, including patients, hospitals, and researchers.   

• The pharmaceutical & biotechnology companies segment held the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.

Based on the end user, the clinical trials matching software market is divided into pharmaceutical & biotechnology companies, CROs, and medical device companies. Among these, the pharmaceutical & biotechnology companies segment held the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. Pharmaceutical and biotechnology companies are due to their significant contributions to medication development and clinical research. Clinical trial matching software is used by these businesses to guarantee regulatory compliance, expedite patient recruitment, and lower trial expenses.

Regional Segment Analysis of the Clinical Trials Matching Software Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the clinical trials matching software market over the predicted timeframe.

North America is anticipated to hold the largest share of the clinical trials matching software market over the predicted timeframe. The market for clinical trial matching software in North America is driven by technology advancements and the growing complexity of clinical studies. Digital solutions are encouraged to increase trial efficiency and compliance by North America's robust healthcare infrastructure and regulatory framework, which includes standards established by the FDA and Health Canada. Machine learning and artificial intelligence (AI) are being combined more and more to improve patient recruitment and expedite trial schedules.

Asia Pacific is expected to grow at the fastest CAGR growth of the clinical trials matching software market during the forecast period. Growing clinical trials in Asia Pacific and the use of cutting-edge technologies like cloud-based solutions and artificial intelligence are driving the market for clinical trials matching software in the region. China's market for clinical trials matching software is developing as a result of the country's growing involvement in international drug research, as well as the growing need for effective clinical trial management.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the clinical trials matching software market along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• IBM
• Microsoft
• Clario
• Advarra
• Curewiki
• Inteliquet (IQVIA)
• Evidation Health, Inc.
• Tempus Labs
• ArisGlobal
• Teckro Limited
• HealthMatch
• Inspirata, Inc.
• Mendel Health Inc.
• Antidote Technologies, Inc.
• Others  

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In September 2024, Massive Bio launched a new project called Patient Connect, which aims to customize access to clinical trials for cancer. The platform matches individuals with appropriate trials based on their unique genetic and medical profiles using AI-driven technologies.

• In September 2023, A conversational AI technology called Tara was launched by the Israeli company Belong. Life to expedite the matching process for cancer clinical trials. Utilizing cutting-edge AI, Tara interacts with patients, collects pertinent medical information, and makes tailored trial recommendations based on each person's unique profile.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the clinical trials matching software market based on the below-mentioned segments: 

Global Clinical Trials Matching Software Market, By Deployment Mode

• Web & Cloud-based
• On-premise

Global Clinical Trials Matching Software Market, By End User

• Pharmaceutical & Biotechnology Companies
• CROs
• Medical Device Companies

Global Clinical Trials Matching Software Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa